Stock Information
Stoke Therapeutics Inc (STOK)
Ticker Symbol: STOK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,856.62 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.36
Revenue (TTM): $0.42 M
Dividend Yield: N/A
ROE: -59.36%
Latest News
-
FDA Alignment on Zorevunersen Endpoints Could Be A Game Changer For Stoke Therapeutics (STOK)
Fri, Oct 9, 2026 11:09 PM
-
Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting
Tue, Oct 6, 2026 12:00 PM
-
Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome
Mon, Oct 5, 2026 11:00 AM
-
Government Study: Cellphone Radiation Linked To Cancer
Mon, Oct 5, 2026 7:10 AM
Key Financials
Financial data not available
